A Phase 2 interventional study of NNC0519-0130 in chronic kidney disease

Recruiting Phase 2 NCT06717698

Study Description

A study comparing different doses of the new medicine NNC0519-0130 for reducing kidney damage in people with chronic kidney disease

Study Details

Registry ID:
NCT06717698
Conditions:
Chronic Kidney Disease
Phase:
Phase 2
Target Enrollment:
465 participants
Start Date:
Healthy Volunteers:
No

Study Locations (175 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.org.

View full study details and check eligibility →